A Randomized Double-Blind Pilot Study of Memantine Augmentation in Antidepressant Nonresponders or Incomplete Responders.
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2014
At a glance
- Drugs Memantine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 02 Feb 2012 Actual patient number (31) added as reported by ClinicalTrials.gov.
- 02 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov